ArticleScientific reports2021

ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19.

Zeynab Fakhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.